BR9806213A - Forma de dosagem transdérmica. - Google Patents

Forma de dosagem transdérmica.

Info

Publication number
BR9806213A
BR9806213A BR9806213-1A BR9806213A BR9806213A BR 9806213 A BR9806213 A BR 9806213A BR 9806213 A BR9806213 A BR 9806213A BR 9806213 A BR9806213 A BR 9806213A
Authority
BR
Brazil
Prior art keywords
transdermal dosage
dosage form
transdermal
relates
present
Prior art date
Application number
BR9806213-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Alfred J Moo-Young
Yun-Yen-Tsong
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of BR9806213A publication Critical patent/BR9806213A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BR9806213-1A 1997-09-17 1998-09-17 Forma de dosagem transdérmica. BR9806213A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5930197P 1997-09-17 1997-09-17
US09/154,287 US20020012694A1 (en) 1997-09-17 1998-09-16 Transdermal administration of ment
PCT/US1998/019399 WO1999013812A1 (en) 1997-09-17 1998-09-17 Transdermal administration of ment

Publications (1)

Publication Number Publication Date
BR9806213A true BR9806213A (pt) 2000-04-18

Family

ID=26738606

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806213-1A BR9806213A (pt) 1997-09-17 1998-09-17 Forma de dosagem transdérmica.

Country Status (6)

Country Link
US (2) US20020012694A1 (enExample)
EP (1) EP0941039A4 (enExample)
JP (1) JP2001527581A (enExample)
BR (1) BR9806213A (enExample)
CA (1) CA2270177C (enExample)
WO (1) WO1999013812A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
AU2003206434A1 (en) * 2002-02-15 2003-09-04 Pantarhei Bioscience B.V. Pulmonary administration of 6-alpha-alkylated testosterone derivatives for androgen replacement therapy
BR0313210A (pt) * 2002-07-24 2005-06-28 Schering Ag Processos microbiológicos para a produção de 11alfa-hidróxi esteróides 7alfa-substituìdos
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US7879357B2 (en) * 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7056332B2 (en) * 2003-07-24 2006-06-06 Materials Evolution And Development Usa, Inc. Nucleic acid biomaterials and methods of formation and use
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
CA2647801C (en) 2006-03-24 2015-04-14 Auxilium Pharmaceuticals, Inc. Process for the preparation of a hot-melt extruded laminate
WO2007112286A2 (en) 2006-03-24 2007-10-04 Auxilium Pharmaceuticals, Inc. Stabilized compositions containing alkaline labile drugs
US20070243714A1 (en) * 2006-04-18 2007-10-18 Applied Materials, Inc. Method of controlling silicon-containing polymer build up during etching by using a periodic cleaning step
US9574043B2 (en) 2009-01-12 2017-02-21 University Of Massachusetts Lowell Polyisobutylene-based polyurethanes
EP2467174B1 (en) * 2009-08-21 2018-09-26 Cardiac Pacemakers, Inc. Crosslinkable polyisobutylene-based polymers and medical devices containing the same
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
US9484123B2 (en) 2011-09-16 2016-11-01 Prc-Desoto International, Inc. Conductive sealant compositions
JP2015535538A (ja) 2012-11-21 2015-12-14 ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ 高強度ポリイソブチレンポリウレタン
US10526429B2 (en) 2017-03-07 2020-01-07 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
CN110997746B (zh) 2017-08-17 2021-12-28 心脏起搏器股份公司 用于增强的耐久性的光交联聚合物
EP3740253B1 (en) 2018-01-17 2023-08-16 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP0500287B1 (en) * 1991-02-20 1995-04-26 Hitachi, Ltd. Catalyzer control apparatus
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
ATE163262T1 (de) * 1993-04-20 1998-03-15 Hexal Ag Wirkstoffplaster
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Also Published As

Publication number Publication date
EP0941039A4 (en) 2006-06-21
CA2270177A1 (en) 1999-03-25
CA2270177C (en) 2006-08-29
US20040126418A1 (en) 2004-07-01
EP0941039A1 (en) 1999-09-15
JP2001527581A (ja) 2001-12-25
US20020012694A1 (en) 2002-01-31
WO1999013812A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
BR9806213A (pt) Forma de dosagem transdérmica.
IT1307274B1 (it) Fibbia.
HN1998000132A (es) Combinaciones terapeuticas
ATA398A (de) Ratschenschnalle
HN1998000099A (es) Formas de dosificacion de sertralina de liberacion retardada
BG106316A (en) Ambroxol-containing lozenge
BR9808642A (pt) Processo para preparar eprosartan
BR9808664A (pt) Processo para preparar eprosartan
NO996520D0 (no) Opploeste sertralinblandinger
HN1998000103A (es) Sales de sertralina y formas de dosificacion de liberacion sostenida de sertralina
ECSP972265A (es) Dihidrato de d-olanzapina
HN1997000147A (es) Procedimientos para piridinas sustituidas
ES1038294Y (es) Pinza para estampacion de matriculas.
BR9700320A (pt) Composto vitaminico para utilização no couro cabeludo
ES1037393Y (es) Pieza de union para acuñado de travesaños.
ES1047329Y (es) Estuche perfeccionado para la presentacion de cinturones.
HN1999000192A (es) Antagonistas de 54t1 para terapia antidepresiva
ES1043262Y (es) Dispositivo para la proteccion de un articulo contra hurtos.
ES1035037Y (es) Dispositivo de abroche para calzado.
ES1040031Y (es) Protector para transformadores.
ES1044507Y (es) Hebilla para calzado perfeccionada
ES1029328Y (es) Expositor-probador antirrobo para joyas.
HN1998000096A (es) Formas de dosificación de solución encapsulada de sertralina
ES1037088Y (es) Piecero para somieres perfeccionado.
ES1038022Y (es) Flexo para duchas.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A CLASSIFICACAO PARA A61K 9/00 E A61F 13/00

Ipc: A61K 9/00, A61F 13/00

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 9/06, A61K 9/12, A61K 9/10, A61K 9/14, A61K 9/70, A61K 31/575, A61L 15/44, A61P 5/24, A61P 19/10, A61P 15/18

Ipc: A61K 9/06 (2007.01), A61K 9/12 (2007.01), A61K 9/1

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DE ACORDO COM ART. 8O DA LPI.